All lobbying filings

HOLLAND & KNIGHT LLP

HOLLAND & KNIGHT LLP filed a Q3 report for NOVO NORDISK, INC. on October 20, 2025, reporting $50,000 in lobbying income.

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

All filings by HOLLAND & KNIGHT LLP · Everything NOVO NORDISK, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Health Issues

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Bills named in this filing 1

H.R. 1577
Treat and Reduce Obesity Act of 2021

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.